1. Home
  2. ALM vs DFTX Comparison

ALM vs DFTX Comparison

Compare ALM & DFTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Almonty Industries Inc.

ALM

Almonty Industries Inc.

HOLD

Current Price

$13.89

Market Cap

5.5B

ML Signal

HOLD

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

N/A

Current Price

$38.45

Market Cap

5.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALM
DFTX
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.9B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
ALM
DFTX
Price
$13.89
$38.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$22.33
$38.50
AVG Volume (30 Days)
5.9M
1.8M
Earning Date
05-20-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$817.94
N/A
Revenue Next Year
$158.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$14.62
52 Week High
$24.41
$49.70

Technical Indicators

Market Signals
Indicator
ALM
DFTX
Relative Strength Index (RSI) 38.97 43.52
Support Level $12.47 $16.37
Resistance Level $14.92 $49.13
Average True Range (ATR) 1.19 1.88
MACD -0.58 -0.08
Stochastic Oscillator 8.55 23.48

Price Performance

Historical Comparison
ALM
DFTX

About ALM Almonty Industries Inc.

Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Share on Social Networks: